Depo-provera Injection, Suspension
Product Images NDC 0009-0746

The document displays a table of odds ratios (with accompanying 95% confidence intervals) obtained from five studies investigating the relationship between long-term use of DMPA (a contraceptive injection) and the risk of developing a specific health condition. The data is presented in logarithmic scale, with each row representing a different study and each column representing a different level of DMPA use. The last row displays the overall odds ratio for all subjects. Odds ratios greater than 1 indicate an increased risk for DMPA use, while odds ratios less than 1 indicate a decreased risk. No information is given about the health condition being investigated, and there is no accompanying text.*

This text appears to be a chart or table regarding different methods of birth control and their effectiveness rates in preventing pregnancy over the course of one year. It lists different methods, such as injections, intrauterine devices, sterilization, birth control pills, condoms, and others, along with their effectiveness rates in terms of number of pregnancies per 100 women. It also includes a section on natural methods of birth control, such as avoiding sex during the most fertile days of the monthly cycle and withdrawal.*

This appears to be a product label for the contraceptive injection Depo-Provera® by Pharmacia & Upjohn Co. It provides instructions on the dosage and use of the medication, specifying that it is for intramuscular use only. The label also includes the National Drug Code and Rx only information. It advises shaking the bottle before use and storing it upright as a table suspension. However, the last line "ikt 150 ma/m" is not clear and its meaning is not available.*

This product is a contraceptive injection called Depo-Provera. The dosage and use details are available in the accompanying prescribing information. Vials of this injection must be stored upright at a controlled room temperature of 20-25°C. The injection contains medroxyprogesterone acetate and is available in a single-dose vial for intramuscular use only. The label also includes the lot number, expiration date, and serial number. However, further details about the usage and precautions need to be consulted before taking this injection.*

Depo-Provera® is a contraceptive injection consisting of 150 mg/mL of medroxyprogesterone acetate in an injectable suspension for intramuscular use only. It is dispensed in a single-dose syringe and requires shaking before use. It is manufactured by Pfizer Inc. The lot number indicated is 802671.*

Depo-Provera is a contraceptive injection that contains medroxyprogesterone acetate. The injection is provided in a 1 mL prefilled syringe and is for intramuscular use only. The recommended storage temperature is between 20° to 25°C, and the injection should be shaken vigorously before use. The syringe comes with a protective cap that must be removed before usage. The medication should be discarded appropriately after use, and the syringe should not be reused for safety reasons. The text also includes details about the preparation of the syringe and other information such as trademarks, manufacturer details, and GTI/LOTEXP/SH codes.*